
1. pediatrics. 2013 aug;132(2):e531-4. doi: 10.1542/peds.2012-3799. epub 2013 jul
22.

acute kernicterus neonate o/b blood group incompatibility a
mutation slc4a1.

christensen rd(1), yaish hm, nussenzveig rh, reading ns, agarwal am, eggert ld,
prchal jt.

author information: 
(1)women newborns program, intermountain healthcare, salt lake city, utah
84403, usa. robert.christensen@imail.org

we cared term female newborn, 108 hours age, total serum
bilirubin 15.4 mg/dl, discharged hospital home phototherapy.
at return appointment 44 hours later, total serum bilirubin 41.7 mg/dl 
and signs acute kernicterus present. maternal/fetal blood group o/b
incompatibility identified, negative direct antiglobulin test, which
was positive retesting. abundant spherocytes blood smear, these
persisted follow-up, neither parent spherocytes identified. a
heterozygous slc4a1(e508k) mutation (gene encoding erythrocyte membrane protein
band 3) found, silico predicted result damaged erythrocyte
cytoskeletal protein function. mutations identified red cell
cytoskeleton genes (ank1, spta1, sptb, epb41, epb42) ugt1a1 promoter
region normal. neurologic follow-up 2 4 months showed developmental
delays consistent mild kernicterus.

doi: 10.1542/peds.2012-3799 
pmid: 23878048  [indexed medline]

